WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDiagnostics & Research
Best Diagnostics & Research Stocks to Buy Now (2022)
Top diagnostics & research stocks in 2022 ranked by overall Zen Score. See the best diagnostics & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.

Industry: Diagnostics & Research
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Consensus
Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
QDEL
QUIDELORTHO CORP
$4.19B$100.18$136.0035.76%Strong Buy1-4.88%N/AN/AN/A
SYNH
SYNEOS HEALTH INC
$7.40B$72.11$98.8637.09%Strong Buy87.36%36.34%21.31%8.47%
MEDP
MEDPACE HOLDINGS INC
$5.18B$153.89$205.0033.21%Buy216.90%9.94%51.61%23.23%
CODX
CO-DIAGNOSTICS INC
$183.53M$5.40$12.00122.22%Buy1-17.26%-50.37%16.34%14.10%
LHDX
LUCIRA HEALTH INC
$68.17M$1.71$3.50104.68%Hold342.33%N/A40.52%27.25%
A
AGILENT TECHNOLOGIES INC
$36.23B$121.29$161.7833.38%Strong Buy94.87%14.17%35.92%17.60%
DGX
QUEST DIAGNOSTICS INC
$16.47B$140.31$152.278.53%Buy12-7.98%-24.72%16.67%7.91%
DMTK
DERMTECH INC
$194.61M$6.50$26.75311.54%Strong Buy593.76%N/A-25.75%-21.88%
DRIO
DARIOHEALTH CORP
$116.75M$5.31$19.00257.82%Strong Buy362.38%N/A20.80%18.65%
PHG
KONINKLIJKE PHILIPS NV
$18.87B$21.69N/AN/ABuy33.73%-17.67%13.21%6.16%
QGEN
QIAGEN NV
$10.61B$46.63$60.0028.67%Buy2-1.66%-0.86%20.36%10.67%
FLGT
FULGENT GENETICS INC
$1.72B$56.79$86.6752.61%Buy3-31.04%-68.78%-1.79%-1.59%
DXCM
DEXCOM INC
$30.49B$77.67$484.92524.33%Strong Buy1217.49%40.50%109.54%47.42%
CSTL
CASTLE BIOSCIENCES INC
$625.80M$23.83$52.25119.26%Strong Buy427.31%N/A-8.00%-7.15%
SERA
SERA PROGNOSTICS INC
$54.14M$1.75$11.50557.14%Buy41,264.02%N/AN/AN/A
RNLX
RENALYTIX PLC
$165.23M$4.57$30.67571.05%Strong Buy3337.00%N/A-53.68%-45.23%
MXCT
MAXCYTE INC
$510.75M$5.03$19.67290.99%Strong Buy520.55%N/A-8.13%-7.33%
TWST
TWIST BIOSCIENCE CORP
$2.31B$41.05$55.0033.98%Buy325.29%N/A-24.70%-20.87%
MOTS
MOTUS GI HOLDINGS INC
$14.37M$0.26$1.50474.71%Buy1230.24%N/A-153.53%-54.10%
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
$11.50B$226.32$372.4464.57%Strong Buy1011.10%22.82%34.92%12.88%
IDXX
IDEXX LABORATORIES INC
$30.37B$361.48$644.4078.27%Buy68.59%11.80%177.39%43.77%
OLK
OLINK HOLDING AB (PUBL)
$1.48B$12.45$28.00124.90%Buy243.21%N/A1.05%0.92%
BWAY
BRAINSWAY LTD
$84.75M$5.15$13.33158.89%Strong Buy317.99%N/A18.91%14.39%
AKU
AKUMIN INC
$50.04M$0.56$3.63548.48%Hold240.42%N/A-84.20%-3.36%
DHR
DANAHER CORP
$186.74B$256.83$325.0026.54%Strong Buy72.99%11.53%18.52%10.30%
ICLR
ICON PLC
$17.99B$220.63$276.4025.28%Strong Buy1012.18%76.34%16.94%7.96%
AWH
ASPIRA WOMEN's HEALTH INC
$57.68M$0.51$3.00483.66%Strong Buy1113.09%N/A-211.58%-149.07%
BNGO
BIONANO GENOMICS INC
$469.31M$1.62$7.00332.10%Strong Buy149.13%N/A-46.55%-41.60%
NRC
NATIONAL RESEARCH CORP
$980.06M$38.90N/AN/AN/AN/AN/AN/AN/AN/A
SENS
SENSEONICS HOLDINGS INC
$467.90M$1.01$6.00494.06%Buy1100.00%N/AN/A-14.78%
CDNA
CAREDX INC
$1.26B$23.68$45.0090.03%Strong Buy110.51%N/A-8.61%-7.20%
PRPO
PRECIPIO INC
$24.07M$1.06$4.00277.36%Strong Buy1N/AN/AN/AN/A
NEOG
NEOGEN CORP
$2.65B$24.61N/AN/AHold17.45%22.67%10.34%9.23%
MTD
METTLER TOLEDO INTERNATIONAL INC
$26.01B$1,146.90$1.38k20.61%Hold34.06%11.51%1,284.33%32.36%
WAT
WATERS CORP
$19.79B$328.58$346.005.30%Hold54.05%7.53%236.80%29.19%
SHC
SOTERA HEALTH CO
$5.88B$20.79$26.0025.06%Buy58.11%50.69%N/AN/A
BNR
BURNING ROCK BIOTECH LTD
$250.16M$2.38$12.90442.02%Strong Buy328.68%N/A-20.40%-16.01%
TMO
THERMO FISHER SCIENTIFIC INC
$213.27B$544.81$649.3819.19%Buy84.23%12.50%25.36%11.20%
NTRA
NATERA INC
$3.99B$41.38$108.80162.93%Strong Buy522.24%N/A-61.27%-29.03%
PSNL
PERSONALIS INC
$181.79M$4.00$23.00475.00%Buy414.42%N/A-34.40%-25.91%
HTGM
HTG MOLECULAR DIAGNOSTICS INC
$4.67M$0.54$3.00451.47%Buy221.30%N/A-74.67%-29.56%
OPGN
OPGEN INC
$27.14M$0.58$3.00414.58%Buy137.00%N/A-55.86%-29.71%
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA INC
$1.26B$5.61$29.00416.93%Buy336.94%N/A-27.49%-10.43%
MYGN
MYRIAD GENETICS INC
$1.52B$18.95$26.0037.20%Hold11.78%N/AN/AN/A
CHEK
CHECK-CAP LTD
$38.18M$0.33$3.00814.63%Buy1N/AN/A-38.83%-35.16%
ANIX
ANIXA BIOSCIENCES INC
$95.37M$3.13$11.00251.44%Strong Buy1N/AN/A-58.72%-57.60%
ONVO
ORGANOVO HOLDINGS INC
$15.42M$1.77N/AN/AN/AN/AN/AN/AN/AN/A
MDXH
MDXHEALTH SA
$107.46M$6.89$16.00132.22%Strong Buy325.02%N/A-272.70%-170.36%
ILMN
ILLUMINA INC
$30.47B$193.93$370.0090.79%Hold814.51%9.32%10.43%7.44%
PKI
PERKINELMER INC
$18.36B$145.53$166.6714.52%Hold3-3.66%8.49%13.60%6.58%
BIOC
BIOCEPT INC
$15.23M$0.90$8.50844.44%Strong Buy2-43.97%N/A-37.02%-22.13%
XGN
EXAGEN INC
$94.29M$5.80$17.00193.10%Strong Buy119.43%N/A-18.14%-11.32%
VIVO
MERIDIAN BIOSCIENCE INC
$1.31B$30.00$30.000.00%Buy1-1.64%0.70%13.73%10.90%
LH
LABORATORY CORP OF AMERICA HOLDINGS
$22.49B$242.56$324.7533.88%Strong Buy8-1.20%-7.30%17.07%8.83%
ME
23ANDME HOLDING CO
$1.25B$2.78$5.0079.86%Buy2N/AN/AN/AN/A
NEO
NEOGENOMICS INC
$1.21B$9.69$24.88156.71%Strong Buy810.17%N/A-2.67%-1.57%
ISPC
ISPECIMEN INC
$20.90M$2.37$16.00575.11%Strong Buy2N/AN/AN/AN/A
BMRA
BIOMERICA INC
$39.58M$3.08$13.00322.11%Buy1N/AN/AN/AN/A
IQV
IQVIA HOLDINGS INC
$40.47B$213.80$271.6327.05%Strong Buy168.41%30.53%46.59%11.04%
CO
GLOBAL CORD BLOOD CORP
$405.22M$3.33N/AN/AN/AN/AN/AN/AN/AN/A
MYNZ
MAINZ BIOMED NV
$121.54M$10.12$25.00147.04%Buy122.98%N/A-309.64%-196.16%
GH
GUARDANT HEALTH INC
$4.71B$46.25$105.00127.03%Strong Buy426.68%N/A-71.70%-17.95%
STIM
NEURONETICS INC
$90.49M$3.38$12.00255.03%Buy26.18%N/A-48.93%-28.84%
NVTA
INVITAE CORP
$703.92M$3.07$11.80284.36%Hold533.10%N/A-15.08%-8.99%
NOTV
INOTIV INC
$299.80M$11.75$60.00410.64%Strong Buy1N/AN/A7.85%4.25%
GTH
GENETRON HOLDINGS LTD
$152.75M$1.65$10.00506.06%Strong Buy1N/AN/AN/AN/A
CELC
CELCUITY INC
$134.72M$9.02$43.25379.49%Strong Buy5N/AN/A-81.31%-62.60%
LNTH
LANTHEUS HOLDINGS INC
$4.31B$62.82$81.2529.34%Strong Buy423.39%N/AN/AN/A
NDRA
ENDRA LIFE SCIENCES INC
$14.28M$0.23$5.002,112.39%Buy1N/AN/A-62.70%-51.99%
AXDX
ACCELERATE DIAGNOSTICS INC
$108.03M$1.36$5.00267.65%Hold138.55%N/AN/AN/A
EXAS
EXACT SCIENCES CORP
$7.94B$45.15$99.38120.10%Buy812.56%N/A-11.66%-5.86%
SLNO
SOLENO THERAPEUTICS INC
$19.45M$0.16$3.001,751.85%Strong Buy1N/AN/A118.00%73.39%
BVS
BIOVENTUS INC
$628.75M$8.15$18.50126.99%Buy213.22%N/A23.67%8.89%
SRDX
SURMODICS INC
$535.54M$38.28$46.0020.17%Buy112.06%N/A-1.15%-0.84%
CEMI
CHEMBIO DIAGNOSTICS INC
$19.64M$0.65N/AN/AHold1N/AN/A-144.64%-61.03%
SQL
SEQLL INC
$9.16M$0.77$3.00289.11%Strong Buy1N/AN/AN/AN/A
HSKA
HESKA CORP
$1.02B$94.62$221.00133.57%Strong Buy414.77%N/A6.37%4.54%
PMD
PSYCHEMEDICS CORP
$35.17M$6.29N/AN/AN/AN/AN/AN/AN/AN/A
VNRX
VOLITIONRX LTD
$112.54M$2.09$9.00330.62%Strong Buy1N/AN/AN/AN/A
RDNT
RADNET INC
$1.02B$18.11$39.00115.35%Buy23.75%-39.39%10.91%1.52%
GENE
GENETIC TECHNOLOGIES LTD
$23.64M$1.28N/AN/AN/AN/AN/AN/AN/AN/A
BDSX
BIODESIX INC
$53.72M$1.35$11.00714.81%Buy226.81%N/A-184.10%-23.24%
CNTG
CENTOGENE NV
$54.84M$2.43$10.00311.52%Strong Buy1-63.72%N/A-121.82%-36.68%
TTOO
T2 BIOSYSTEMS INC
$25.76M$0.15$0.70366.67%Strong Buy1N/AN/AN/AN/A
OPK
OPKO HEALTH INC
$1.80B$2.64$5.0089.39%Buy2-9.83%N/A0.84%0.59%
ENZ
ENZO BIOCHEM INC
$101.83M$2.09N/AN/AN/AN/AN/AN/AN/AN/A
TRIB
TRINITY BIOTECH PLC
$28.43M$1.36N/AN/AN/AN/AN/AN/AN/AN/A
QTNT
QUOTIENT LTD
$26.68M$0.26$7.002,592.31%Strong Buy1N/AN/A-8.17%4.91%
LMDX
LUMIRADX LTD
$746.57M$2.95$13.67363.29%Strong Buy3N/AN/AN/A-6.53%
LAB
STANDARD BIOTOOLS INC
$135.19M$1.75$10.00471.43%Strong Buy1N/AN/AN/AN/A
PRE
PRENETICS GLOBAL LTD
$466.11M$4.20$15.00257.14%Strong Buy1N/AN/AN/A-2.62%

Diagnostics & Research Stocks FAQ

What are the best diagnostics & research stocks to buy right now in Jun 2022?

According to Zen Score, the 3 best diagnostics & research stocks to buy right now are:

1. Quidelortho (NASDAQ:QDEL)


Quidelortho (NASDAQ:QDEL) is the top diagnostics & research stock with a Zen Score of 64, which is 30 points higher than the diagnostics & research industry average of 34. It passed 20 out of 33 due diligence checks and has strong fundamentals. Quidelortho has seen its stock lose -12.86% over the past year, overperforming other diagnostics & research stocks by 15 percentage points.

Quidelortho has an average 1 year price target of $136.00, an upside of 35.76% from Quidelortho's current stock price of $100.18.

Quidelortho stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Quidelortho, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Syneos Health (NASDAQ:SYNH)


Syneos Health (NASDAQ:SYNH) is the second best diagnostics & research stock with a Zen Score of 56, which is 22 points higher than the diagnostics & research industry average of 34. It passed 18 out of 33 due diligence checks and has strong fundamentals. Syneos Health has seen its stock lose -16.45% over the past year, overperforming other diagnostics & research stocks by 12 percentage points.

Syneos Health has an average 1 year price target of $98.86, an upside of 37.09% from Syneos Health's current stock price of $72.11.

Syneos Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Syneos Health, 62.5% have issued a Strong Buy rating, 12.5% have issued a Buy, 25% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Medpace Holdings (NASDAQ:MEDP)


Medpace Holdings (NASDAQ:MEDP) is the third best diagnostics & research stock with a Zen Score of 55, which is 21 points higher than the diagnostics & research industry average of 34. It passed 19 out of 33 due diligence checks and has strong fundamentals. Medpace Holdings has seen its stock lose -13.53% over the past year, overperforming other diagnostics & research stocks by 15 percentage points.

Medpace Holdings has an average 1 year price target of $205.00, an upside of 33.21% from Medpace Holdings's current stock price of $153.89.

Medpace Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Medpace Holdings, 0% have issued a Strong Buy rating, 50% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the diagnostics & research stocks with highest dividends?

Out of 9 diagnostics & research stocks that have issued dividends in the past year, the 3 diagnostics & research stocks with the highest dividend yields are:

1. Koninklijke Philips Nv (NYSE:PHG)


Koninklijke Philips Nv (NYSE:PHG) has an annual dividend yield of 4.44%, which is 3 percentage points higher than the diagnostics & research industry average of 1.27%. Koninklijke Philips Nv's dividend payout is not stable, having dropped more than 10% three times in the last 10 years. Koninklijke Philips Nv's dividend has not shown consistent growth over the last 10 years.

Koninklijke Philips Nv's dividend payout ratio of 24.8% indicates that its high dividend yield is sustainable for the long-term.

2. Psychemedics (NASDAQ:PMD)


Psychemedics (NASDAQ:PMD) has an annual dividend yield of 1.91%, which is 1 percentage points higher than the diagnostics & research industry average of 1.27%. Psychemedics's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Psychemedics's dividend has not shown consistent growth over the last 10 years.

Psychemedics's dividend payout ratio of -38.5% indicates that its dividend yield might not be sustainable for the long-term.

3. Quest Diagnostics (NYSE:DGX)


Quest Diagnostics (NYSE:DGX) has an annual dividend yield of 1.8%, which is 1 percentage points higher than the diagnostics & research industry average of 1.27%. Quest Diagnostics's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Quest Diagnostics's dividend has shown consistent growth over the last 10 years.

Quest Diagnostics's dividend payout ratio of 16.4% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostics & research stocks up?

Diagnostics & research stocks were up 1.7% in the last day, and up 8.08% over the last week.

We couldn't find a catalyst for why diagnostics & research stocks are up.

What are the most undervalued diagnostics & research stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued diagnostics & research stocks right now are:

1. Quidelortho (NASDAQ:QDEL)


Quidelortho (NASDAQ:QDEL) is the most undervalued diagnostics & research stock based on WallStreetZen's Valuation Score. Quidelortho has a valuation score of 100, which is 65 points higher than the diagnostics & research industry average of 35. It passed 7 out of 7 valuation due diligence checks.

Quidelortho's stock has dropped -12.86% in the past year. It has overperformed other stocks in the diagnostics & research industry by 15 percentage points.

2. Syneos Health (NASDAQ:SYNH)


Syneos Health (NASDAQ:SYNH) is the second most undervalued diagnostics & research stock based on WallStreetZen's Valuation Score. Syneos Health has a valuation score of 71, which is 36 points higher than the diagnostics & research industry average of 35. It passed 5 out of 7 valuation due diligence checks.

Syneos Health's stock has dropped -16.45% in the past year. It has overperformed other stocks in the diagnostics & research industry by 12 percentage points.

3. Co Diagnostics (NASDAQ:CODX)


Co Diagnostics (NASDAQ:CODX) is the third most undervalued diagnostics & research stock based on WallStreetZen's Valuation Score. Co Diagnostics has a valuation score of 71, which is 36 points higher than the diagnostics & research industry average of 35. It passed 5 out of 7 valuation due diligence checks.

Co Diagnostics's stock has dropped -37.93% in the past year. It has underperformed other stocks in the diagnostics & research industry by -10 percentage points.

Are diagnostics & research stocks a good buy now?

50% of diagnostics & research stocks rated by analysts are a strong buy right now. On average, analysts expect diagnostics & research stocks to rise by 52.21% over the next year.

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is 31.07x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.